Using Treg, Tr1, and Breg Expression Levels to Predict Clinical Responses to csDMARD Treatment in Drug-naive Patients With Rheumatoid Arthritis.

MLA

Ting-Yu Hsieh, et al. “Using Treg, Tr1, and Breg Expression Levels to Predict Clinical Responses to CsDMARD Treatment in Drug-Naive Patients With Rheumatoid Arthritis.” In Vivo, vol. 37, no. 5, Sept. 2023, pp. 2018–27. EBSCOhost, https://doi.org/10.21873/invivo.13299.

APA

Ting-Yu Hsieh, Shan-Wen Lui, Jeng-Wei Lu, Yen-Chen Chen, Ting-Chun Lin, Wun-Long Jheng, Yi-Jung Ho, & Feng-Cheng Liu. (2023). Using Treg, Tr1, and Breg Expression Levels to Predict Clinical Responses to csDMARD Treatment in Drug-naive Patients With Rheumatoid Arthritis. In Vivo, 37(5), 2018–2027. https://doi.org/10.21873/invivo.13299

Chicago

Ting-Yu Hsieh, Shan-Wen Lui, Jeng-Wei Lu, Yen-Chen Chen, Ting-Chun Lin, Wun-Long Jheng, Yi-Jung Ho, and Feng-Cheng Liu. 2023. “Using Treg, Tr1, and Breg Expression Levels to Predict Clinical Responses to CsDMARD Treatment in Drug-Naive Patients With Rheumatoid Arthritis.” In Vivo 37 (5): 2018–27. doi:10.21873/invivo.13299.